FDA issues alert on Ellume at-home COVID-19 tests

By LabPulse.com staff writers

October 5, 2021 -- Some home tests for COVID-19 manufactured by Ellume may deliver false-positive results due to a manufacturing issue, according to a safety communication issued October 5 by the U.S. Food and Drug Administration (FDA).

The FDA said the incorrect results only occurred in certain lots of the Ellume COVID-19 Home Test, and that negative test results did not appear to be affected by the issue. The agency said it was working with Ellume on corrective steps to address the reason for the manufacturing issue and to resolve the problem.

The FDA issued emergency use authorization for the test in December 2020, which at the time was the first for an over-the-counter, fully at-home diagnostic test for COVID-19. The test is a rapid lateral-flow antigen test, a type of diagnostic test that runs a liquid sample along a surface with reactive molecules, detecting protein fragments of SARS-CoV-2 from nasal swabs.

FDA issues EUA for Ellume's at-home COVID-19 test
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for an over-the-counter at-home diagnostic test for COVID-19...

Copyright © 2021 LabPulse.com

Last Updated ls 10/5/2021 3:28:09 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current